Based on the popular 80s card game, each week we select an asset class and use FE fundinfo data to compare two funds based on their three-year performance, assets under management, alpha, volatility, ongoing charges and information ratio to decide which is the Top Trump.
This week, the BNP Paribas Healthcare Innovators fund defeats the Schroder International Selection Fund Healthcare Innovation fund 5-1.
BNP Paribas Healthcare Innovators fund
The fund seeks to increase the value of its assets over the medium term by investing in shares issued worldwide by companies which innovate or benefit from healthcare innovation.
Geographical breakdown:
- USA (70.9%)
- UK (8.5%)
- Denmark (5.2%)
- France (5.1%)
- Switzerland (3.1%)
- Japan (2.8%)
- Belgium (2.6%)
- Canada (0.6%)
- Cash (1.4%)
Schroder International Selection Fund Healthcare Innovation fund
The fund aims to provide capital growth by investing in equity and equity related securities of healthcare and medical related companies worldwide which meet the investment manager’s sustainability criteria.
Geographical breakdown:
- USA (61.1%)
- Denmark (9.8%)
- UK (7.3%)
- Switzerland (4.7%)
- Germany (2.6%)
- Sweden (2.6%)
- Belgium (1.8%)
- Australia (1.8%)
- Japan (1.5%)
- France (0.8%)
